简 繁 EN
Menu
Milestones
Milestones
Chengxi Pharmaceutical Factory Established

JumpCan Pharmaceutical's history traces back to Taixing Chengxi Pharmaceutical Factory, founded in 1967 — a legacy spanning 59 years

1967

Jichuan Pharmaceutical Group Established

1998

Restructured from State-owned to Private Joint-Stock

2001

First Entry into Top 100 Chinese Pharmaceutical Industrial Enterprises

2004
Successfully Listed
Successfully listed on the Shanghai Stock Exchange, stock code: 600566
2013
Acquired Dongke Pharmaceutical, Established Pudilan Cosmetics & Toiletries

Acquired and established Shaanxi Dongke Pharmaceutical Co., Ltd. and Jiangsu Pudilan Cosmetics & Toiletries Co., Ltd. marking a solid step in capital M&A

2014
Partnership with TJ Biopharma

JumpCan entered into a strategic partnership valued at nearly RMB 2 billion, setting a new benchmark in recent years for similar transactions in China’s biopharmaceutical market and the global pediatric pharmaceutical sector.

2021
Partnership with Newsoara Biopharma

JumpCan reached a project collaboration valued at RMB 400 million, introducing an innovative oral PDE4 phosphodiesterase inhibitor and a targeted digestive protease inhibitor.

2022
Partnership with Zenshine Pharmaceuticals
JumpCan signed a co-promotion agreement for polymerase acidic protein inhibitors used for the treatment or prevention of influenza, further deepening the partnership between the two companies.
2023
Culture Upgrade
Officially released the new vision "Build a joyful and vibrant life together," simultaneously updating the six core values and their corresponding behaviors
2025
Multiple Commercial Partnerships
JumpCan entered into partnerships with PrimeGene, Akeso, and Zedman Pharma for pumecitinib nasal spray, 伊喜宁®, and 泽立美®, respectively, marking continued progress in the commercialization of innovative medicines.
2026